Publication Cover
Redox Report
Communications in Free Radical Research
Volume 28, 2023 - Issue 1
1,824
Views
0
CrossRef citations to date
0
Altmetric
Research Article

LncRNA Fendrr: involvement in the protective role of nucleolin against H2O2-induced injury in cardiomyocytes

, , , , , , , & show all

References

  • Tajrishi MM, Tuteja R, Tuteja N. Nucleolin: the most abundant multifunctional phosphoprotein of nucleolus. Commun Integr Biol. 2011 May;4(3):267–275.
  • Andersen JS, Lyon CE, Fox AH, et al. Directed proteomic analysis of the human nucleolus. Curr Biol. 2002 Jan 8;12(1):1–11.
  • Jia W, Yao Z, Zhao J, et al. New perspectives of physiological and pathological functions of nucleolin (NCL). Life Sci 2017 Oct 1;186:1–10.
  • Wang K, Deng G, Chen G, et al. Heat shock protein 70 inhibits hydrogen peroxide-induced nucleolar fragmentation via suppressing cleavage and down-regulation of nucleolin. Cell Stress Chaperones. 2012 Jan;17(1):121–130.
  • Zhang B, Wang H, Jiang B, et al. Nucleolin/C23 is a negative regulator of hydrogen peroxide-induced apoptosis in HUVECs. Cell Stress Chaperones. 2010 May;15(3):249–257.
  • Jiang B, Zhang B, Liang P, et al. Nucleolin/C23 mediates the antiapoptotic effect of heat shock protein 70 during oxidative stress. FEBS J. 2010 Feb;277(3):642–652.
  • Jiang B, Zhang B, Liang P, et al. Nucleolin protects the heart from ischaemia-reperfusion injury by up-regulating heat shock protein 32. Cardiovasc Res. 2013 Jul 1;99(1):92–101.
  • Jiang B, Liang P, Wang K, et al. Nucleolin involved in myocardial ischaemic preconditioning via post-transcriptional control of HSPA1A expression. Cardiovasc Res. 2014 Apr 1;102(1):56–67.
  • Liu J, Li Y, Lin B, et al. Hbl1 is a human long noncoding RNA that modulates cardiomyocyte development from pluripotent stem cells by counteracting MIR1. Dev Cell. 2017 Aug 21;42(4):333–348.e5.
  • Boon RA, Jae N, Holdt L, et al. Long noncoding RNAs: from clinical genetics to therapeutic targets? J Am Coll Cardiol. 2016 Mar 15;67(10):1214–1226.
  • Piccoli MT, Gupta SK, Viereck J, et al. Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction. Circ Res. 2017 Aug 18;121(5):575–583.
  • Song C, Qi H, Liu Y, et al. Inhibition of lncRNA Gm15834 attenuates autophagy-mediated myocardial hypertrophy via the miR-30b-3p/ULK1 axis in mice. Mol Ther: J Am Soc Gene Ther. 2021 Mar 3;29(3):1120–1137.
  • Chen C, Liu M, Tang Y, et al. LncRNA H19 is involved in myocardial ischemic preconditioning via increasing the stability of nucleolin protein. J Cell Physiol. 2020 Sep;235(9):5985–5994.
  • Wu Q, Wang R, Shi Y, et al. Synthesis and biological evaluation of panaxatriol derivatives against myocardial ischemia/reperfusion injury in the rat. Eur J Med Chem. 2020 Jan 1;185:111729.
  • Wang S, Chen X, Wang M, et al. Long non-coding RNA CYP4B1-PS1-001 inhibits proliferation and fibrosis in diabetic nephropathy by interacting with nucleolin. Cell Physiol Biochem. 2018;49(6):2174–2187.
  • Zhang G, Wang Q, Zhang X, et al. LncRNA FENDRR suppresses the progression of NSCLC via regulating miR-761/TIMP2 axis. Biomed Pharmacother. 2019 Oct;118:109309.
  • Zhang M, Cheng K, Chen H, et al. LncRNA AK020546 protects against cardiac ischemia-reperfusion injury by sponging miR-350-3p. Aging. 2021 May 13;13(10):14219–14233.
  • Lu M, Tian H, Cao YX, et al. Downregulation of miR-320a/383-sponge-like long non-coding RNA NLC1-C (narcolepsy candidate-region 1 genes) is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation. Cell Death Dis. 2015 Nov 5;6(11):e1960.
  • Huang M, Huang X, Jiang B, et al. Linc00174-EZH2-ZNF24/Runx1-VEGFA regulatory mechanism modulates post-burn wound healing. Molecular Therapy Nucleic Acids. 2020 Sep 4;21:824–836.
  • Grote P, Wittler L, Hendrix D, et al. The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013 Jan 28;24(2):206–214.
  • Li Y, Zhang W, Liu P, et al. Long non-coding RNA FENDRR inhibits cell proliferation and is associated with good prognosis in breast cancer. Onco Targets Ther. 2018;11:1403–1412.
  • Rosello-Lleti E, Rivera M, Cortes R, et al. Influence of heart failure on nucleolar organization and protein expression in human hearts. Biochem Biophys Res Commun. 2012 Feb 10;418(2):222–228.
  • Xu TP, Huang MD, Xia R, et al. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression. J Hematol Oncol. 2014 Aug 29;7:63.
  • Kun-Peng Z, Xiao-Long M, Chun-Lin Z. LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1. Oncotarget. 2017 Sep 22;8(42):71881–71893.
  • Liu J, Du W. LncRNA FENDRR attenuates colon cancer progression by repression of SOX4 protein. Onco Targets Ther. 2019;12:4287–4295.
  • Kontaraki JE, Marketou ME, Kochiadakis GE, et al. The long non-coding RNAs MHRT, FENDRR and CARMEN, their expression levels in peripheral blood mononuclear cells in patients with essential hypertension and their relation to heart hypertrophy. Clin Exp Pharmacol Physiol. 2018 Nov;45(11):1213–1217.
  • Cuesta-Llavona E, Lorca R, Rolle V, et al. Association of the genetic variation in the long Non-coding RNA FENDRR with the risk of developing hypertrophic cardiomyopathy. Life. 2022 May 30;12(6).
  • Wang X, Yu H, Sun W, et al. The long non-coding RNA CYTOR drives colorectal cancer progression by interacting with NCL and Sam68. Mol Cancer. 2018 Jul 31;17(1):110.
  • Ginisty H, Sicard H, Roger B, et al. Structure and functions of nucleolin. J Cell Sci. 1999;112(Pt 6):761–772.
  • Shen Y, Liu S, Fan J, et al. Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. EMBO Rep. 2017 Apr;18(4):536–548.
  • Wang F, Zhou S, Qi D, et al. Understanding the effects of coordination and self-assembly on an emissive phenothiazine. J Am Chem Soc 2019 Feb 27;141(8):3717–3722.
  • Sun H, Tong Z, Fang Y, et al. Nucleolin protects against doxorubicin-induced cardiotoxicity via upregulating microRNA-21. J Cell Physiol. 2018 Dec;233(12):9516–9525.